Adenoviral vectors as novel vaccines for influenza.
OBJECTIVES: Influenza is a viral respiratory disease causing seasonal epidemics, with significant annual illness and mortality. Emerging viruses can pose a major pandemic threat if they acquire the capacity for sustained human-to-human transmission. Vaccination reduces influenza-associated mortality...
Päätekijät: | Coughlan, L, Mullarkey, C, Gilbert, S |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2015
|
Samankaltaisia teoksia
-
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Tekijä: Lynda Coughlan
Julkaistu: (2020-05-01) -
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
Tekijä: Jingao Guo, et al.
Julkaistu: (2018-07-01) -
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Tekijä: Ekramy E. Sayedahmed, et al.
Julkaistu: (2020-10-01) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2017) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Katie Ewer, et al.
Julkaistu: (2017-12-01)